Bioxyne (ASX:BXN) received commitments to raise AU$3 million via the placing of 120 million new shares at AU$0.025 apiece, according to a Friday Australian bourse filing.
It will also issue 60 million options on the basis of one option for every two new shares, with an exercise price of AU$0.05 and an expiry date of two years from the date of issue.
It will use the proceeds to support its expansion into European markets as well as the establishment and certification of medical cannabis manufacturing facilities in the UK and Czechia.
Its directors will participate in the amount of AU$110,000, subject to shareholder approval.
Alpine Capital was the sole lead manager and book runner to the placement.
免责声明：投资有风险，本文并非投资建议，以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请，作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考，不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证，投资者应自行研究并在投资前寻求专业建议。